How big is the global ADHD market?
The global ADHD market is expected to reach USD 21.9 billion by 2030, growing at a CAGR of 4.3% during 2023-2030. This significant growth is fueled by rising diagnoses, increasing awareness, and advancements in treatment options.
Which region is the largest market for ADHD treatment?
North America currently dominates the global ADHD market, accounting for over 62% of the market share in 2022. This is due to factors like high awareness, advanced healthcare infrastructure, and significant investment in R&D.
Who are the major players in the ADHD market?
Some of the leading companies in the global ADHD market include Supernus Pharmaceuticals, Pfizer, Novartis, Eli Lilly, and GlaxoSmithKline. These companies are developing and marketing a range of ADHD medications, diagnostic tools, and digital solutions.
What are the key drivers of ADHD market growth?
The increasing prevalence of ADHD, growing public awareness, advancements in treatment options, and rising R&D efforts are driving market growth.